- Home
- CPIX vs CRT Comparison
CPIX vs CRT Comparison
Compare CPIX & CRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPIX
- CRT
- Stock Information
- Founded
- CPIX 1999
- CRT 1991
- Country
- CPIX United States
- CRT United States
- Employees
- CPIX N/A
- CRT N/A
- Industry
- CPIX Biotechnology: Pharmaceutical Preparations
- CRT Oil & Gas Production
- Sector
- CPIX Health Care
- CRT Energy
- Exchange
- CPIX Nasdaq
- CRT Nasdaq
- Market Cap
- CPIX 68.7M
- CRT 64.0M
- IPO Year
- CPIX 2009
- CRT 1992
- Fundamental
- Price
- CPIX $4.36
- CRT $12.26
- Analyst Decision
- CPIX
- CRT
- Analyst Count
- CPIX 0
- CRT 0
- Target Price
- CPIX N/A
- CRT N/A
- AVG Volume (30 Days)
- CPIX 112.7K
- CRT 33.6K
- Earning Date
- CPIX 03-04-2025
- CRT 01-01-0001
- Dividend Yield
- CPIX N/A
- CRT 8.11%
- EPS Growth
- CPIX N/A
- CRT N/A
- EPS
- CPIX N/A
- CRT 0.95
- Revenue
- CPIX $37,867,945.00
- CRT $6,623,430.00
- Revenue This Year
- CPIX N/A
- CRT N/A
- Revenue Next Year
- CPIX N/A
- CRT N/A
- P/E Ratio
- CPIX N/A
- CRT $13.92
- Revenue Growth
- CPIX N/A
- CRT N/A
- 52 Week Low
- CPIX $1.04
- CRT $8.88
- 52 Week High
- CPIX $7.25
- CRT $14.98
- Technical
- Relative Strength Index (RSI)
- CPIX 44.29
- CRT 61.40
- Support Level
- CPIX $3.91
- CRT $11.60
- Resistance Level
- CPIX $4.47
- CRT $12.43
- Average True Range (ATR)
- CPIX 0.34
- CRT 0.52
- MACD
- CPIX -0.15
- CRT 0.15
- Stochastic Oscillator
- CPIX 26.63
- CRT 61.91
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
About CRT Cross Timbers Royalty Trust
Cross Timbers Royalty Trust is a United States based trust. Its principal asset is the net profits interests. The net profits interests are derived from producing royalty, overriding royalty interests, and working interests properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.